What is Lab7 Systems?
L7 Informatics, operating as Lab7 Systems, provides the AI-ready unifying platform, L7|ESP®, tailored for the life sciences sector. This comprehensive solution is designed to streamline complex workflows, contextualize vast amounts of data, and enhance AI-driven decision-making processes. Its client base spans pharmaceutical companies, biotechnology firms, diagnostic laboratories, and research institutions, offering best-of-breed applications, compliance services, and operational assessments to drive digital transformation. By partnering with clients, L7 Informatics aims to dismantle data silos and optimize operational efficiency, thereby enabling organizations to achieve peak innovation and productivity.
How much funding has Lab7 Systems raised?
Lab7 Systems has raised a total of $3.5M across 2 funding rounds:
Debt
$500K
Series A
$3M
Debt (2012): $500K, investors not publicly disclosed
Series A (2016): $3M, investors not publicly disclosed
What's next for Lab7 Systems?
The substantial enterprise-level funding context suggests Lab7 Systems is in a scaling phase, likely focusing on expanding its market reach and further developing its AI capabilities within the life sciences. The recent strategic investment indicates a strong validation of its platform and business model. Future endeavors will probably involve deepening its integration with key industry players, enhancing its AI-driven analytics, and potentially exploring new verticals within the broader healthcare and research ecosystem. Continued investment in platform development and strategic partnerships will be crucial for maintaining its competitive edge and driving sustained growth.
See full Lab7 Systems company page
